BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 25843912)

  • 1. Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study.
    Inoue K; Anai S; Fujimoto K; Hirao Y; Furuse H; Kai F; Ozono S; Hara T; Matsuyama H; Oyama M; Ueno M; Fukuhara H; Narukawa M; Shuin T
    Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):193-200. PubMed ID: 25843912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).
    Inoue K; Matsuyama H; Fujimoto K; Hirao Y; Watanabe H; Ozono S; Oyama M; Ueno M; Sugimura Y; Shiina H; Mimata H; Azuma H; Nagase Y; Matsubara A; Ito YM; Shuin T
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():91-96. PubMed ID: 26751700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
    Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG
    BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
    O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
    BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study.
    Nakai Y; Inoue K; Tsuzuki T; Shimamoto T; Shuin T; Nagao K; Matsuyama H; Oyama M; Furuse H; Ozono S; Miyake M; Fujimoto K
    Int J Urol; 2018 Aug; 25(8):723-729. PubMed ID: 29999205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
    Inoue K; Fukuhara H; Shimamoto T; Kamada M; Iiyama T; Miyamura M; Kurabayashi A; Furihata M; Tanimura M; Watanabe H; Shuin T
    Cancer; 2012 Feb; 118(4):1062-74. PubMed ID: 21773973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence ureterorenoscopy for urinary upper tract urothelial carcinoma ∼Preliminary prospective single centre trial∼.
    Fukuhara H; Kurabayashi A; Furihata M; Setuda S; Takahashi K; Murakami K; Tanaka T; Inoue K
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101617. PubMed ID: 31857216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytology.
    Neuzillet Y; Methorst C; Schneider M; Lebret T; Rouanne M; Radulescu C; Molinie V; Dreyfus JF; Pelcat V; Botto H
    Urol Oncol; 2014 Nov; 32(8):1135-40. PubMed ID: 25023786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experience with intravesical instillations of 5-aminolevulinic acid (5-ALA) for the photodynamic diagnosis using fluorescence cystoscopy for bladder cancer].
    Inoue K; Karashima T; Kamada M; Kurabayashi A; Ohtsuki Y; Shuin T
    Nihon Hinyokika Gakkai Zasshi; 2006 Jul; 97(5):719-29. PubMed ID: 16898595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Utility of a Flexible Fluorescence-Cystoscope with a Twin Mode Monitor for the 5-Aminolevulinic Acid-Mediated Photodynamic Diagnosis of Bladder Cancer.
    Fukuhara H; Kureishi M; Khoda T; Inoue K; Tanaka T; Iketani K; Orita M; Inoue K; Shuin T
    PLoS One; 2015; 10(9):e0136416. PubMed ID: 26332041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo fluorescence navigation of gastric and upper gastrointestinal tumors by 5-aminolevulinic acid mediated photodynamic diagnosis with a laser-equipped video image endoscope.
    Isomoto H; Nanashima A; Senoo T; Ogiwara K; Hashisako M; Ohnita K; Yamaguchi N; Kunizaki M; Hidaka S; Fukuda H; Ishii H; Matsushima K; Minami H; Akazawa Y; Takeshima F; Fukuoka J; Nagayasu T; Nakao K
    Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):201-8. PubMed ID: 25840141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
    Rink M; Babjuk M; Catto JW; Jichlinski P; Shariat SF; Stenzl A; Stepp H; Zaak D; Witjes JA
    Eur Urol; 2013 Oct; 64(4):624-38. PubMed ID: 23906669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world experience with 5-aminolevulinic acid for the photodynamic diagnosis of bladder cancer: Diagnostic accuracy and safety.
    Yamamoto S; Fukuhara H; Karashima T; Inoue K
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():101999. PubMed ID: 32920180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexyl aminolevulinate: 5-ALA hexylester, 5-ALA hexylesther, aminolevulinic acid hexyl ester, hexaminolevulinate, hexyl 5-aminolevulinate, P 1206.
    Drugs R D; 2005; 6(4):235-8. PubMed ID: 15991884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France].
    Rouprêt M; Malavaud B; Molinier L; Leleu H; Blachier M; Marteau F
    Prog Urol; 2015 Apr; 25(5):256-64. PubMed ID: 25605343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL).
    Bader MJ; Stepp H; Beyer W; Pongratz T; Sroka R; Kriegmair M; Zaak D; Welschof M; Tilki D; Stief CG; Waidelich R
    Urol Oncol; 2013 Oct; 31(7):1178-83. PubMed ID: 22440147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the management of bladder cancer with fluorescence cystoscopy.
    Grossman HB
    J Environ Pathol Toxicol Oncol; 2007; 26(2):143-7. PubMed ID: 17725540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved diagnosis and long-term recurrence rate reduction for non-muscle-invasive bladder cancer patients undergoing fluorescent hexylaminolevulinate photodynamic diagnosis.
    Drăgoescu PO; Tudorache Ş; Drocaş AI; Mitroi G; Pănuş A; Drăgoescu NAM; Meşină C; Mititelu CD; Stănculescu AD; Mohamed G; Tomescu PI
    Rom J Morphol Embryol; 2017; 58(4):1279-1283. PubMed ID: 29556618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
    Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
    BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trial.
    Stenzl A; Penkoff H; Dajc-Sommerer E; Zumbraegel A; Hoeltl L; Scholz M; Riedl C; Bugelnig J; Hobisch A; Burger M; Mikuz G; Pichlmeier U
    Cancer; 2011 Mar; 117(5):938-47. PubMed ID: 21351082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.